Evidence map›Paper›PMID 38778448›Full record

ArticleClinical and translational medicine2024

Integrating single-cell and spatial analysis reveals MUC1-mediated cellular crosstalk in mucinous colorectal adenocarcinoma.

Haiyang Zhou, Yiwen Shen, Guangyong Zheng, Beibei Zhang, Anqi Wang, Jing Zhang, Hao Hu, Jiayi Lin, Sanhong Liu, Xin Luan and 1 more

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Journal of gastrointestinal oncology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Thrombospondin-1 induces CD8Journal of ovarian research · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haiyang ZhouShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID 0000-0003-2782-1821
Yiwen ShenShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Guangyong ZhengShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Beibei ZhangDepartment of Dermatology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Anqi WangDepartment of Colorectal Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Jing ZhangDepartment of Pathology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Hao HuDepartment of Pathology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jiayi LinShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Sanhong LiuShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xin LuanShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID 0000-0003-3674-256X
Weidong ZhangShanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Funding

2021 Shanghai Science and Technology Innovation Action Plan 21S11902800CAMS Innovation Fund for Medical Sciences 2023-I2M-3-009Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine ZYYCXTD-D-202004National Key R&D Program of China 2019YFA0110601National Key R&D Program of China 2022YFC3502000National Natural Science Foundation of China 81571827National Natural Science Foundation of China 82173846National Natural Science Foundation of China 82322073National Natural Science Foundation of China 82374086Oriental Scholars of Shanghai TP2022081Shanghai Rising-Star Program 22QA1409100The Thousand Talents Plan of Jiangxi Province jxsq2023102168Three-year Action Plan for Shanghai TCM Development and Inheritance Program ZY(2021-2023)-0208Three-year Action Plan for Shanghai TCM Development and Inheritance Program ZY(2021-2023)-0401Young Talent Lifting Project of China Association of Chinese Medicine 2021-QNRC2-A08
6 · The paper itself

Abstract

backgroundMucinous colorectal adenocarcinoma (MCA) is a distinct subtype of colorectal cancer (CRC) with the most aggressive pattern, but effective treatment of MCA remains a challenge due to its vague pathological characteristics. An in-depth understanding of transcriptional dynamics at the cellular level is critical for developing specialised MCA treatment strategies.

methodsWe integrated single-cell RNA sequencing and spatial transcriptomics data to systematically profile the MCA tumor microenvironment (TME), particularly the interactome of stromal and immune cells. In addition, a three-dimensional bioprinting technique, canonical ex vivo co-culture system, and immunofluorescence staining were further applied to validate the cellular communication networks within the TME.

resultsThis study identified the crucial intercellular interactions that engaged in MCA pathogenesis. We found the increased infiltration of FGF7

conclusionsOur study provides novel insights into communications among tumour cells with stromal and immune cells that are significantly enriched in the TME during MCA progression, presenting potential prognostic biomarkers and therapeutic strategies for MCA. KEY POINTS: Tumour microenvironment profiling of MCA is developed. MUC1

Indexed as

Adenocarcinoma, MucinousColorectal NeoplasmsMucin-1Single-Cell AnalysisTumor MicroenvironmentCell CommunicationHumansMUC1 protein, humanMucin-1mucinous colorectal adenocarcinomascRNA‐seqspatial transcriptomicstumour microenvironment

Identifiers

PMID38778448
PMCPMC11111627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.